Palisade Bio PEG Ratio

Palisade Bio posts a PEG ratio of -1.23. That is above the Healthcare sector average of -6.46. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For Healthcare stocks, a PEG ratio near -6.46 is typical. Palisade Bio's -1.23 is higher that level. That is roughly 80.9% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Palisade Bio's PEG ratio of -1.23 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.

Context for PALI's PEG ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average -6.46), and (3) consistency with growth and profitability. This page covers the first two; Palisade Bio's other metric pages and overview cover the third.

Judging Palisade Bio against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in PEG ratio easier to interpret. Start with -1.23 here, then scan peer and history charts to see if the gap is persistent.